GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Maven Brands Inc (OTCPK:TRLFF) » Definitions » Earnings Yield (Joel Greenblatt) %

Maven Brands (Maven Brands) Earnings Yield (Joel Greenblatt) % : -12.95% (As of Dec. 2022)


View and export this data going back to 2017. Start your Free Trial

What is Maven Brands Earnings Yield (Joel Greenblatt) %?

Maven Brands's Enterprise Value for the quarter that ended in Dec. 2022 was $4.90 Mil. Maven Brands's EBIT for the trailing twelve months (TTM) ended in Dec. 2022 was $-0.64 Mil. Maven Brands's Earnings Yield (Joel Greenblatt) for the quarter that ended in Dec. 2022 was -12.95%.

The historical rank and industry rank for Maven Brands's Earnings Yield (Joel Greenblatt) % or its related term are showing as below:

TRLFF's Earnings Yield (Joel Greenblatt) % is not ranked *
in the Drug Manufacturers industry.
Industry Median: 2.36
* Ranked among companies with meaningful Earnings Yield (Joel Greenblatt) % only.

Joel Greenblatt's definition of earnings yield has the same problems the regular earnings yield does. It does not consider the growth of the company. It only looks at one-year's business operation. For cyclical companies, the earnings yield is usually highest at the peak of the business cycle. But these earnings are rarely sustainable.

A better indicator of the attractiveness of an investment which takes growth into account is the Forward Rate of Return (Yacktman) %. Maven Brands's Forward Rate of Return (Yacktman) % for the quarter that ended in Dec. 2022 was 0.00%. The Forward Rate of Return uses the normalized Free Cash Flow of the past seven years, and considers growth. The forward rate of return can be thought of as the return that investors buying the stock today can expect from it in the future.


Maven Brands Earnings Yield (Joel Greenblatt) % Historical Data

The historical data trend for Maven Brands's Earnings Yield (Joel Greenblatt) % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Maven Brands Earnings Yield (Joel Greenblatt) % Chart

Maven Brands Annual Data
Trend Dec14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22
Earnings Yield (Joel Greenblatt) %
Get a 7-Day Free Trial Premium Member Only -6.41 -6.50 -117.65 -13.91 -19.12

Maven Brands Quarterly Data
Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22
Earnings Yield (Joel Greenblatt) % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -21.69 -19.12 -17.86 -17.54 -12.95

Competitive Comparison of Maven Brands's Earnings Yield (Joel Greenblatt) %

For the Drug Manufacturers - Specialty & Generic subindustry, Maven Brands's Earnings Yield (Joel Greenblatt) %, along with its competitors' market caps and Earnings Yield (Joel Greenblatt) % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Maven Brands's Earnings Yield (Joel Greenblatt) % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Maven Brands's Earnings Yield (Joel Greenblatt) % distribution charts can be found below:

* The bar in red indicates where Maven Brands's Earnings Yield (Joel Greenblatt) % falls into.



Maven Brands Earnings Yield (Joel Greenblatt) % Calculation

In his book, The Little That Beat the Market, hedge fund manager Joel Greenblatt defines Earnings Yield as operating income divided by enterprise value.

Maven Brandss Earnings Yield (Joel Greenblatt) for the fiscal year that ended in Mar. 2022 is calculated as

Earnings Yield (Joel Greenblatt)=EBIT/Enterprise Value
=-1.527/8.05495094
=-18.96 %

Maven Brands's EBIT for the trailing twelve months (TTM) ended in Dec. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.64 Mil.



Maven Brands  (OTCPK:TRLFF) Earnings Yield (Joel Greenblatt) % Explanation

Joel Greenblatt defines the earnings yield using the above equation because it more accurately reflects the company's profitability relative to its stock price. Items like interest payment and tax etc. are not directly related to the company's operational profitability.

Enterprise Value instead of market cap (share price) is used in the calculation because it is the real price stock and bond investors together pay for the company.


Be Aware

Joel Greenblatt's definition of earnings yield has the same problems the regular earnings yield does. It does not consider the growth of the company. It only looks at one-year's business operation. For cyclical companies, the earnings yield is usually highest at the peak of the business cycle. But these earnings are rarely sustainable.

Forward Rate of Return (Yacktman) % based on Don Yacktman's definition is a better measure of the expected rate of return for a stock.


Maven Brands Earnings Yield (Joel Greenblatt) % Related Terms

Thank you for viewing the detailed overview of Maven Brands's Earnings Yield (Joel Greenblatt) % provided by GuruFocus.com. Please click on the following links to see related term pages.


Maven Brands (Maven Brands) Business Description

Industry
Traded in Other Exchanges
N/A
Address
100 Kalamalka Lake Road, Unit 32, Vernon, BC, CAN, V1T 9G1
Maven Brands Inc is a licensed producer of medicinal cannabis for the Canadian market under Canada's Marihuana for Medical Purposes Regulations program administered by Health Canada. The company is launching an innovative services program to provide seed-to-shelf solutions for cannabis micro-cultivators and small-scale producers across Canada. Its services will be designed to support craft growers on a path to the regulated market and will operate from the True Leaf Campus facility located in Lumby, British Columbia.